Ospedale San Bortolo

Running trials

• Recruiting

  Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  NCT07504458· Phase 3· Quetzal Therapeutics· Source

• Not yet recruiting

  A multicenter, multicohort, phase 2 platform trial to personalize second-line treatment intensity and targeting in HR-positive, HER2-negative metastatic breast cancer through an integrated liquid biopsy algorithm.

  2025-523460-21-00· Phase 2· Centro Di Riferimento Oncologico Di Aviano· Source

• Recruiting

  A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

  NCT07203768· FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS· Source

• Recruiting

  MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 translational study.

  NCT04091204· Phase 2· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Source

• Recruiting

  Pericardiotomy in Cardiac Surgery

  NCT06486636· Population Health Research Institute· Source

• Recruiting

  Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

  NCT06533813· FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS· Source

• Recruiting

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source

• Recruiting

  The ReTAVI Prospective Observational Registry

  NCT05601453· Institut für Pharmakologie und Präventive Medizin· Source

• Active, not recruiting

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Boston Scientific Corporation· Source

• Recruiting

  Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

  NCT06506084· FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS· Source

• Active, not recruiting

  Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant NSCLC according to TP53 mutational status (TEMPLE-2)

  2024-517424-18-00· Phase 4· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source

• Active, not recruiting

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· Phase 3· Jazz Pharmaceuticals· Source

• Enrolling by invitation

  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  NCT04574076· Novo Nordisk A/S· Source

• Recruiting

  Metformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi-centre, 2 parallel arms randomized controlled trial

  NCT03764605· Phase 3· University Of Bari Aldo Moro· Source

• Completed

  IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

  NCT02967289· Phase 3· UNICANCER· Source

• Active, not recruiting

  Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

  NCT01761968· Phase 2· Italfarmaco· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms3 recruiting
• Acute myeloid leukaemia2 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Haemophilia1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Polycystic kidney disease1 recruiting

Closed trials

• Completed

  LOW-PV Continuation

  NCT06752941· FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Janssen-Cilag Ltd.· Source

• Completed

  Cenobamate in Adults With Focal-Onset Seizures

  NCT05859854· Aziende Chimiche Riunite Angelini Francesco S.p.A· Source

• Completed

  Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

  NCT06408324· European Research Consortium on ITP· Source

• Completed

  A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

  NCT01827605· Phase 3· Fondazione Italiana Linfomi - ETS· Source

• Completed

  Indolent Non Follicular Lymphomas Prognostic Project

  NCT02904577· Fondazione Italiana Linfomi - ETS· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Atopic dermatitis (eczema)19 works · 0 trials
• Chronic myeloid leukaemia5 works · 0 trials
• Mantle cell lymphoma5 works · 0 trials
• Immune thrombocytopenia (ITP)4 works · 1 trial